Home/Filings/4/0001209191-16-144514
4//SEC Filing

BIOLASE, INC 4

Accession 0001209191-16-144514

CIK 0000811240operating

Filed

Oct 3, 8:00 PM ET

Accepted

Oct 4, 5:28 PM ET

Size

9.5 KB

Accession

0001209191-16-144514

Insider Transaction Report

Form 4
Period: 2016-09-30
Flynn Harold C Jr.
DirectorPresident and CEO
Transactions
  • Conversion

    Common Stock

    2016-09-30$1.13/sh+35,400$40,00235,400 total(indirect: By Trust)
  • Conversion

    Series C Participating Convertible Preferred Stock

    2016-09-303540 total(indirect: By Trust)
    Exercise: $1.13From: 2016-09-30Common Stock (35,400 underlying)
Holdings
  • Common Stock

    66,959
Footnotes (6)
  • [F1]On September 30, 2016, as a result of receipt of the Requisite Stockholder Approval (defined and described further in the Securities Purchase Agreement dated August 1, 2016 and filed as Exhibit 99.1 to the Current Report on Form 8-K filed by the Issuer on August 2, 2016), each share of Preferred Stock (as defined below) automatically converted into 100 shares of Common Stock, reflecting a conversion price equal to $1.13 per share.
  • [F2]The Common Stock is held directly by the Flynn Living Trust (the "Trust"). Mr. Flynn serves as a co-trustee to the Trust and his daughter is the beneficiary of the Trust.
  • [F3]These shares of Series C Participating Convertible Preferred Stock ("Preferred Stock") were acquired by the Trust in a private placement with the Issuer, which closed on August 8, 2016.
  • [F4]The Preferred Stock had no expiration date.
  • [F5]The Preferred Stock was held directly by the Trust. Mr. Flynn serves as a co-trustee to the Trust and his daughter is the beneficiary of the Trust.
  • [F6]The Reporting Person disclaims beneficial ownership of the Preferred Stock except to the extent of his pecuniary interest therein, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the Preferred Stock for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.

Issuer

BIOLASE, INC

CIK 0000811240

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0000811240

Filing Metadata

Form type
4
Filed
Oct 3, 8:00 PM ET
Accepted
Oct 4, 5:28 PM ET
Size
9.5 KB